Preventing the Inflammatory Response to Experimentally-induced Insomnia Symptoms

NCT02268565 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Aspirin
DRUG: Placebo

Sponsor

Beth Israel Deaconess Medical Center